Are you Dr. Luckey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 S Orange Ave
Livingston, NJ 07039Phone+1 973-322-7430Fax+1 973-322-7460
Summary
- Dr. Marjorie Luckey, MD is an endocrinologist in Livingston, New Jersey. She is currently licensed to practice medicine in New Jersey, New York, and California. She is affiliated with Cooperman Barnabas Medical Center.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1982
University of California (San Francisco)Residency, Internal Medicine, 1974 - 1976- University of California (San Francisco)Internship, Internal Medicine, 1973 - 1974
Medical College of Georgia at Augusta UniversityClass of 1973
Certifications & Licensure
CA State Medical License 1975 - Present
NJ State Medical License 1997 - 2025
NY State Medical License 1978 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 361 citationsInterpretation and use of FRAX in clinical practiceJohn A. Kanis, Didier Hans, Cyrus Cooper, Sanford Baim, J. P. Bilezikian
Osteoporosis International. 2011-07-21 - 152 citationsDaily and Cyclic Parathyroid Hormone in Women Receiving AlendronateFelicia Cosman, Jeri W. Nieves, Marsha Zion, Lillian Woelfert, Marjorie M. Luckey
The New England Journal of Medicine. 2005-08-11 - 24 citationsTherapeutic equivalence of alendronate 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosisMarjorie M Luckey, Nigel Gilchrist, Henry G. Bone, Michael W Davie, Tobias J. de Villiers
Obstetrics and Gynecology. 2003-04-01
Press Mentions
Barnabas Health in the Community: Project Healthy Bones Instructors HonoredAugust 1st, 2013
Grant Support
- Effect On Bone Density Of Daily Oral Mk-217 In Recently Postmenopausal WomenNational Center For Research Resources1992–1995
- Intermittent Cyclical Tiludronate In Established Post-Menopausal OsteoporosisNational Center For Research Resources1993–1994
- Cyclical Tiludronate--Women With Low Bone Mineral Mass--No Vertebral FracturesNational Center For Research Resources1993–1994
- Influence Of RACE And Age On Bone HomeostasisNational Center For Research Resources1988
- Influence Of RACE And Gender On Bone Mass And Homeostatic MechanismsNational Center For Research Resources1985–1987
